---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-015174"
form_type: "8-K"
ticker: "NUTX"
cik: "0001479681"
company_name: "Nutex Health Inc."
filed_at: "2026-03-05T23:59:59+00:00"
generated_at: "2026-05-15T19:31:46.320393+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Nutex Health FY2025 revenue up 82% to $875M, diluted EPS $10.48; announces $25M buyback

## Summary
- FY2025 total revenue $875.3M, up 82.4% YoY; net income $70.8M vs $52.1M; diluted EPS $10.48 vs $9.69.
- Q4 revenue $151.7M (-41.1% YoY) due to $55M arbitration true-up and $69M arbitration revenue recorded in Q4 2024.
- Q4 net income $11.8M vs $61.6M; EBITDA $25.7M vs $78.9M; Adjusted EBITDA $16.6M vs $86.7M.
- Board authorized $25M stock repurchase program over 6 months to offset dilution from earn-out shares for hospitals.
- Remediated all previously disclosed material weaknesses in internal controls over financial reporting in 2025.

## SEC filing metadata
- accession: 0001628280-26-015174
- form_type: 8-K
- ticker: NUTX
- cik: 0001479681
- company_name: Nutex Health Inc.
- filed_at: 2026-03-05T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1479681/000162828026015174/0001628280-26-015174-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1479681/000162828026015174/nutx-20260305.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-015174
- JSON: https://secwatch.observer/filing/0001628280-26-015174.json
- Plain text: https://secwatch.observer/filing/0001628280-26-015174.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.